title: Imaging tumor angiogenesis: the road to clinical utility.
abstract: OBJECTIVE
  Tumor growth and progression require the formation of new blood vessels from preexisting vasculature, a process called angiogenesis. The ability to noninvasively visualize angiogenesis may provide new opportunities to more appropriately select patients for antiangiogenesis treatment and to monitor treatment efficacy.
  
  
  CONCLUSIONS
  The superior molecular sensitivity of PET and the lack of radiation from MRI and contrast-enhanced ultrasound put these techniques at the forefront of clinical translation.
authors.affiliation: Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, Rm H-0101, Stanford, CA 94305, USA. aiagaru@stanford.edu
authors.forename: Andrei
authors.initials: A
authors.lastname: Iagaru
authors.forename: Sanjiv Sam
authors.initials: SS
authors.lastname: Gambhir
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003287:Contrast Media; D003952:Diagnostic Imaging; D018450:Disease Progression; D006801:Humans; D009389:Neovascularization, Pathologic / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D020533:Angiogenesis Inhibitors; D003287:Contrast Media